395 related articles for article (PubMed ID: 36262473)
21. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
Wu T; Li N; Luo F; Chen Z; Ma L; Hu T; Hong G; Li H
BMC Bioinformatics; 2023 Apr; 24(1):176. PubMed ID: 37120506
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival.
Liu T; Yuan Z; Wang H; Wang J; Xue L
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):101835. PubMed ID: 34798303
[TBL] [Abstract][Full Text] [Related]
23. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
[TBL] [Abstract][Full Text] [Related]
24. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
Gong M; Liu X; Zhao X; Wang H
BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
[TBL] [Abstract][Full Text] [Related]
25. Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma.
Li N; Ren SH; Qin YF; Shao B; Qin H; Wang Z; Wang HD; Li GM; Zhu YL; Sun CL; Zhang JY; Shi GG; An XW; Wang H
Biomed Res Int; 2022; 2022():2680110. PubMed ID: 35782053
[TBL] [Abstract][Full Text] [Related]
26. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
[TBL] [Abstract][Full Text] [Related]
27. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
Yu H; Bai X; Zheng W
Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
[TBL] [Abstract][Full Text] [Related]
28. Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma.
Chen J; Tao Q; Lang Z; Gao Y; Jin Y; Li X; Wang Y; Zhang Y; Yu S; Lv B; Yu Z; Lin C
Oxid Med Cell Longev; 2022; 2022():4494713. PubMed ID: 35069975
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
Xing M; Li J
BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
[TBL] [Abstract][Full Text] [Related]
30. A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma.
Zhou C; Zhan G; Jin Y; Chen J; Shen Z; Shen Y; Deng H
Aging (Albany NY); 2021 Dec; 13(24):25960-25979. PubMed ID: 34910689
[TBL] [Abstract][Full Text] [Related]
31. Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma.
Liu S; Shao R; Bu X; Xu Y; Shi M
Front Cell Dev Biol; 2021; 9():742994. PubMed ID: 34820372
[TBL] [Abstract][Full Text] [Related]
32. A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques.
Wang Z; Bao A; Liu S; Dai F; Gong Y; Cheng Y
Front Genet; 2022; 13():801056. PubMed ID: 35464869
[TBL] [Abstract][Full Text] [Related]
33. A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.
Chen Y; Zhu Y; Dong Y; Li H; Gao C; Zhu G; Mi X; Li C; Xu Y; Wang G; Cai S; Han Y; Xu C; Wang W; Yang S; Ji W
Front Oncol; 2023; 13():1085188. PubMed ID: 37051536
[TBL] [Abstract][Full Text] [Related]
34. A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma.
Lin D; Chen Z; Zeng Y; Ding Y; Zhao L; Xu Q; Yu F; Song X; Zhu X
BMC Med Genomics; 2023 Jan; 16(1):2. PubMed ID: 36611208
[TBL] [Abstract][Full Text] [Related]
35. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
36. Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma.
Zheng S; Xie X; Guo X; Wu Y; Chen G; Chen X; Wang M; Xue T; Zhang B
Front Genet; 2021; 12():789296. PubMed ID: 34925465
[TBL] [Abstract][Full Text] [Related]
37. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
38. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer.
Liu S; Zeng C; Lv H; Zhang Y; Xiong H; Tang H
Dis Markers; 2022; 2022():7570494. PubMed ID: 36601599
[TBL] [Abstract][Full Text] [Related]
39. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]